Probing Degrader Safety Liabilities and Target Biology in Relevant Cellular Contexts
9:30 am - Tuesday 27th October 2026
- Flagging CRBN neosubstrate liabilities with a Lumit immunoassay panel for rapid degradation profiling in unmodified cells
- Uncovering cell context-dependent degradation potency, highlighting the importance of disease-relevant models for translational research
- Developing next-generation tagging tools to study endogenous target biology and degradation
